loading

Coya Therapeutics Inc Azioni (COYA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2,078%
3.5643
0.1636 0.2579 0.00195 -
Operating Expenses
8.83%
5.9972
6.5781 7.9348 4.0822 4.4503
Benefits Costs and Expenses
100.00%
-
6.2586 7.5646 3.638 4.0214
Costs And Expenses
4.18%
5.9972
6.2586 7.5646 3.638 4.0214
Operating Income/Loss
62.07%
-2.4329
-6.4145 -7.6769 -4.0803 -4.4503
Income/Loss From Continuing Operations Before Tax
158.48%
3.5643
-6.095 -7.3068 -3.6361 -4.0214
Income/Loss From Continuing Operations After Tax
65.29%
-2.1158
-6.095 -7.3068 -2.9158 -4.0214
Net Income/Loss
65.29%
-2.1158
-6.095 -7.3068 -2.9158 -4.0214
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.05%
16.73
16.72 16.72 0.3728 15.22
Diluted Average Shares
0.05%
16.73
16.72 16.72 0.3728 15.22
Basic Earnings Per Share
63.89%
-0.13
-0.36 -0.44 -0.18 -0.26
Diluted Earnings Per Share
63.89%
-0.13
-0.36 -0.44 -0.18 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):